Titomic Limited
TITMF
Other OTC0.15
USD
- -
- -
ISIN
AU000000TTT3
Return %
Stock
S&P500
1Y
-3.93
26.57
3Y
-27.20
76.60
5Y
-64.50
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jim Simpson
- Full Time Employees
- 74
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 365 Ferntree Gully Road Mount Waverley VIC Australia 3149
- IPO Date
- May 11, 2020
- Website
- titomic.com
- Similar Companies
- Business
- Titomic Limited (ASX: TTT; OTC: TITMF) specializes in integrated solutions for industrial-scale metal additive manufacturing, coatings, and repairs using its patented Titomic Kinetic Fusion cold spray technology; the company provides original equipment manufacturer production, research and development services, cold spray additive manufacturing machines, manufactured products, metal coating and repair services, powder supply, training, and repair-as-a-service offerings to the global aerospace, defense, shipbuilding, oil and gas, mining, and automotive industries. Titomic operates in Australia, the United States, Europe, and the Asia-Pacific region, with its global headquarters and primary 59,000 sq. ft. manufacturing facility in Huntsville, Alabama, and additional facilities in Mount Waverley, Australia, and Heerenveen, Netherlands; founded in 2014, the company targets high-performance applications requiring superior strength, faster turnaround, and sustainability advantages over traditional fabrication methods. Recent developments include a 37% revenue increase to AUD 8.1 million for the fiscal year ended June 30, 2025; AUD 80 million in capital raisings comprising AUD 30 million in October 2024 and AUD 50 million in July 2025 to fund U.S. expansion; inauguration of the Huntsville facility in June 2025; leadership enhancements with CEO Jim Simpson, U.S. President Dr. Patti Dare, and board addition of Retired Lt. Gen. John Frewen; establishment of a U.S. Strategic Advisory Group; sales to Northrop Grumman, NAVSEA, Triton Systems, and others; progressing Tier 1 engagements with Boeing, Northrop Grumman, and Airbus MRO pilots; securing U.S. titanium and refractory metal supply agreements; selection for the CRP DefenseTech Accelerator; appointment of Aude Vignelles as Asia-Pacific President; and a pivot to high-margin recurring services alongside a change in financial year-end to December 31.
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI
Titomic lands $1.7 million Royal NLR order for cold spray systems
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback
Microsoft price target lowered on M365, Copilot questions
Atlassian to reduce headcount by 10% as it restructures around AI
Titomic plans US redomicile as defence market focus grows
Tap Global shares rise 6% as directors lock in 63% of shares for three years
Titomic Limited (TITMF) Shareholder/Analyst Call Transcript